Watchlist Price Alert

Maze Therapeutics Inc. (MAZE)

NASDAQ: MAZE · Real-Time Price · USD

12.87

-0.47 (-3.52%)

At close: Jun 06, 2025, 3:59 PM

12.59

-2.18%

After-hours: Jun 06, 2025, 05:57 PM EDT

Maze Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q1 2025	Q4 2024	Q3 2024	Q4 2023	Q3 2023
Period Ending	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Dec 31, 2023	Sep 30, 2023
Net Income	-113.69M	-105.66M	-76.08M	-51.32M	-24.75M
Depreciation & Amortization	3.15M	3.47M	2.77M	1.98M	1M
Stock-Based Compensation	10.98M	9.86M	7.01M	4.67M	2.11M
Other Working Capital	-6.08M	-5.87M	-6.08M	-2.02M	206K
Other Non-Cash Items	10.84M	11.53M	8.99M	5.34M	695K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-6.45M	-5.49M	-6.52M	-1.28M	963K
Operating Cash Flow	-95.82M	-86.27M	-63.82M	-40.62M	-19.97M
Capital Expenditures	-1.04M	-739K	-134K	-31K	3K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-1.04M	-739K	-134K	-31K	3K
Debt Repayment	16.18M	16.18M	16.18M	16.18M	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	195.5M	68.13M	-2.13M	20K	8K
Financial Cash Flow	211.68M	84.31M	14.05M	16.2M	8K
Net Cash Flow	114.82M	-2.7M	-49.91M	-24.45M	-19.96M
Free Cash Flow	-96.86M	-87.01M	-63.95M	-40.65M	-19.97M